Citius Pharmaceuticals Inc. Common (CTXR)
NASDAQ · Manufacturing · Pharmaceutical preparations
CTXR price, last 12 months
Key stats
- Previous close
- $0.5107
- Open
- $0.5200
- Day range
- $0.4829 – $0.5201
- 52-week range
- $0.3699 – $1.54
- Volume
- 141.3K
- Avg volume (20 days)
- 263.6K
- Market cap
- $14.7M
Performance
Technicals and fundamentals
About Citius Pharmaceuticals Inc. Common
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $14.7M